Globalstar vs Relay Therapeutics Inc. Common Stock — how do they compare? Globalstar trades at $82.76 (market cap $10.78B), while Relay Therapeutics Inc. Common Stock trades at $17.59 (market cap $3.82B). The key difference: Globalstar is far larger — about 2.8× Relay Therapeutics Inc. Common Stock's market cap, and Globalstar is trading nearer its 52-week high, Relay Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globalstar for 20 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| GSAT | RLAY | |
|---|---|---|
Market Cap | $10.78B | $3.82B |
Volume | 723,953 | 4,332,079 |
Sector | Media | Health |
52-Week High | $84.43 | $20.75 |
52-Week Low | $41.54 | $6.03 |
Typical Hold Time | 20 Days | 0 Days |
Enterprise Value | $10.79B | $2.93B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Globalstar provides satellite and terrestrial connectivity services, including voice, data, asset tracking, and private wireless solutions. It operates a low-Earth-orbit satellite network and holds licensed mid-band spectrum.
Read more on GSAT →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →